| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 4 |
| 1 | APIXABAN | 3 |
| 2 | FLUOROURACIL | 3 |
| 3 | FLUOROURACIL CREAM, 0.5% | 3 |
| 4 | OXALIPLATIN | 3 |
| 5 | RIVAROXABAN | 2 |
| 6 | ABALOPARATIDE | 1 |
| 7 | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL | 1 |
| 8 | ADALIMUMAB | 1 |
| 9 | ALBUTEROL | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CEVIMELINE HYDROCHLORIDE | 1 | 0.0004 |
| 1 | TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM | 1 | 0.0001 |
| 2 | VANCOMYCIN HYDROCHLORIDE | 1 | 0.0001 |
| 3 | CLOTRIMAZOLE TOPICAL | 1 | 0.0001 |
| 4 | CLOTRIMAZOLE | 1 | 0.0001 |
| 5 | CEFEPIME HYDROCHLORIDE | 1 | 0.0001 |
| 6 | TIZANIDINE HYDROCHLORIDE | 1 | 0.0001 |
| 7 | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM | 1 | 0.0001 |
| 8 | APIXABAN | 3 | 0.0000 |
| 9 | OXALIPLATIN | 3 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Parathyroid Hormone-Related Peptide Analog [EPC] | 1 | 0.0000 |
| 1 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 4 | 0.0000 |
| 2 | Ester Local Anesthetic [EPC] | 1 | 0.0000 |
| 3 | Glycopeptide Antibacterial [EPC] | 1 | 0.0000 |
| 4 | Non-Standardized Chemical Allergen [EPC] | 1 | 0.0000 |
| 5 | Amide Local Anesthetic [EPC] | 1 | 0.0000 |
| 6 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 1 | 0.0000 |
| 7 | Platinum-based Drug [EPC] | 3 | 0.0000 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 3 | 0.0000 |
| 9 | Factor Xa Inhibitor [EPC] | 3 | 0.0000 |